Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription
Many users find once-daily dosing more sustainable over multi-week protocols
What are the benefits of BPC 157
Individuals with Medical Conditions : Conditions like Crohns disease, celiac disease, and pernicious anemia can impair B12 absorption
However, differences in absorption, safety, and effectiveness are not well established in large human trials
A 200 ug/kg or 2 ug/kg dose of BPC 157 was intraperitoneally injected 10 minutes post-injury followed by the return of animals to their cages and assignment to interval groups varying from days 7, 15, 20, 90, 180, and 360
US$ 28.05
US$ 28.12
US$ 20.94
US$ 27.29
US$ 23.99
US$ 20.48
US$ 24.29
US$ 24.61
US$ 23.27
US$ 25.01
